scorecardresearch

Cipla

 

More Stories on Cipla
Stocks in focus: Muthoot Finance, Jindal Steel, ICICI Bank, Future Retail, Kaveri Seed, Bharti Airtel, Cipla, sugar stocks and more

Stocks in news: Bharti Airtel, Jindal Steel, ICICI Bank, Cipla and more

Aug 26, 2021

Stocks to watch out for: Bharti Airtel, Jindal Steel, Future Retail, Kaveri Seed and more

Cipla Limited will hold a 60 per cent stake in the JV company on a fully diluted basis, the pharma major said in another regulatory filing

Cipla, Kemwell Biopharma enter JV to develop biosimilars

Aug 25, 2021

The two companies will incorporate the JV for this purpose with an aim to enter the respiratory biosimilars space, Cipla said in a regulatory filing

Cipla share price tanks 4% post Q1 results; here's what brokerages say

Cipla share price tanks 4% post Q1 results; here's what brokerages say

Aug 06, 2021

The company posted a net profit of Rs 709.92 crore in the April-June quarter of the current fiscal compared to Rs 566.04 in the same quarter of the previous fiscal

Stocks in news: Adani Power, Cipla, Maruti Suzuki, Future Retail, Escorts and more

Stocks in news: Adani Power, Cipla, Maruti Suzuki, Future Retail, Escorts and more

Aug 06, 2021

On Thursday, the equity indices closed at record highs for the third consecutive session, despite profit-booking in the last hour of trade. Sensex ended 123 points higher at 54,492 and Nifty climbed 35 points to 16,294

Cipla saw its India business grow 68 per cent year-on-year from Rs 1,608 crore in Q1 of FY21 to Rs 2,710 crore in the April-June quarter of FY22

Cipla's profit jumps 24% YoY to Rs 715 cr in Apr-June quarter; revenue up 27%

Aug 05, 2021

Cipla registered a 27 per cent YoY jump in revenue from operations at Rs 5,504 crore during the June-end quarter. The pharma firm’s EBITA stood Rs 1,346 crore in Q1 of FY22, compared to Rs 1,039 crore in Q1 of last year

India has been offered 7.5 million doses of Moderna's COVID-19 vaccine (Source: PTI)

7.5 million doses of Moderna vaccine offered to India: report

Jul 20, 2021

Moderna's COVID-19 vaccine was granted emergency use authorisation by India's drug regulator last month

Last week, India's drug controller had granted approval to the import of Moderna's mRNA COVID-19 vaccine through Cipla

Moderna COVID-19 vaccine: India offers legal indemnity, but with riders

Jul 10, 2021

The proposal, which has been further sent to Moderna, will be taken up by its board of directors and once granted approval, will enable immediate import by India of around seven million doses of the company's vaccine

Stocks in news: IRCTC, Cipla, Ruchi Soya, Emami Realty, IndusInd Bank and more

Stocks in news: IRCTC, Cipla, Ruchi Soya, RIL, IndusInd Bank and more

Jun 30, 2021

Stocks in news: IRCTC, Cipla, Ruchi Soya, Emami Realty and more

Cipla gets DCGI nod to import Moderna COVID-19 vaccine

Jun 29, 2021

Cipla has been given approval for emergency use in the country

Cipla may get DCGI approval to import Moderna vaccine

Cipla may import Moderna’s COVID-19 vaccine; approval likely today

Jun 29, 2021

The pharma company had filed an application with DCGI seeking approval to import the vaccine on June 28

Stocks in news: Reliance Industries, Cipla, Dabur India, Adani Ports, Apollo Hospitals, Tata Motors, and more

Stocks in news: Reliance Industries, Adani Ports, Tata Motors, Shyam Metalics and more

Jun 24, 2021

Stocks in news: Reliance Industries, Cipla, Dabur India, Adani Ports, Apollo Hospitals, Tata Motors, and more